3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
23
Lymphoma
16
Osteosarcoma
11
Lymphoma, Large B-Cell, Diffuse
11
Hodgkin Disease
11
Testicular Neoplasms
10
Lymphoma, Non-Hodgkin
10
Teratoma
8
Ovarian Neoplasms
7
Testicular Germ Cell Tumor
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Neoplasms
6
Burkitt Lymphoma
6
Recurrence
5
Endodermal Sinus Tumor
5
Central Nervous System Neoplasms
5
Carcinoma, Embryonal
5
Lymphoma, Large-Cell, Anaplastic
4
Seminoma
3
Rhabdomyosarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Germ Cell Cancer
3
Neurofibrosarcoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell
3
Histiocytoma, Malignant Fibrous
3
Fibrosarcoma
3
Vomiting
2
Sarcoma, Synovial
2
Sarcoma, Alveolar Soft Part
2
Interventions
Hydroxyurea
3
Bevacizumab
3
pembrolizumab
2
Imatinib Mesylate
2
Everolimus
2
vistusertib
1
vatalanib
1
pasireotide
1
fludarabine phosphate
1
fludarabine
1
arginyllysine
1
antineoplaston AS 2-1
1
antineoplaston A10
1
aldesleukin
1
Whole Body Imaging
1
Verapamil
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiosurgery
1
Proton Therapy
1
Nivolumab
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
HDAC-42
1
Fentanyl
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Meningioma
×
Ifosfamide
×
Clear all
No trials found.